1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA LIX1L CTRPv2 pan-cancer AAC -0.23 4e-07
mRNA AMPD2 CTRPv2 pan-cancer AAC -0.21 2e-07
mRNA TERF2IP CTRPv2 pan-cancer AAC -0.21 2e-06
mRNA EDC4 CTRPv2 pan-cancer AAC -0.21 3e-07
mRNA ARL3 CTRPv2 pan-cancer AAC -0.2 8e-07
mRNA SYDE1 CTRPv2 pan-cancer AAC -0.19 6e-05
mRNA BRD8 CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA GNA11 CTRPv2 pan-cancer AAC -0.19 0.0001
mRNA PRPS1 CTRPv2 pan-cancer AAC -0.19 2e-06
mRNA EID2B CTRPv2 pan-cancer AAC -0.18 7e-06
Download CSV